Cellceutix Comments on New York Times Article Heralding P53 Drugs as the …
Cellceutix Comments on New York Times Article Heralding p53 Drugs as the …
Filed under: drug treatment news 2011
BEVERLY, MA–(Marketwire – Dec 24, 2012) – Cellceutix Corporation ( OTCBB : CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant …
Read more on Marketwire (press release)
Central Coast lawmakers have new laws on tap
Filed under: drug treatment news 2011
The bill renews the state's place at the forefront of a national debate about immigration and was furiously opposed by many when it passed in 2011. But vows to repeal it, including an aborted petition … It takes an aggressive stand, requiring …
Read more on Santa Cruz Sentinel
Business briefcast
Filed under: drug treatment news 2011
The Food and Drug Administration said in a letter sent last month and released publicly last week that batches of the wrinkle treatment shipped by suppliers owned by pharmacy Canada Drugs have not been approved by the FDA and that the agency cannot …
Read more on Winston-Salem Journal
Global rheumatology market controlled by Enbrel, Humira and Remicade
Filed under: drug treatment news 2011
In March 2011, the Food and Drug Administration approved GlaxoSmithKline's (LSE: GSK) Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) and, in July 2011, it was approved by the European Medicines Agency. Celebrex and …
Read more on The Pharma Letter